|
Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
RECRUITINGPhase 2Sponsored by Second Affiliated Hospital of Guangzhou Medical University
Actively Recruiting
PhasePhase 2
SponsorSecond Affiliated Hospital of Guangzhou Medical University
Started2020-11-01
Est. completion2029-11-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04770207
Summary
To study the safety and clinical effect of injection of drug-eluting microspheres with multiple chemodrug and/or protein drugs into advanced solid tumors.
Eligibility
Age: 18 Years – 99 YearsHealthy volunteers accepted
Inclusion Criteria: * Solid advanced malignant tumors * Age between18 and 99 years * Life expectancy is greater than three months Exclusion Criteria: * Benign tumor * Life expectancy is less than three months * Serious medical comorbidity * Others
Conditions6
CancerHepatocellular CarcinomaLiver CancerLiver DiseaseLung CancerSolid Tumor, Adult
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorSecond Affiliated Hospital of Guangzhou Medical University
Started2020-11-01
Est. completion2029-11-01
Eligibility
Age18 Years – 99 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04770207